Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report)'s share price shot up 3.5% during trading on Thursday . The company traded as high as $30.70 and last traded at $30.64. 806,835 shares traded hands during trading, a decline of 78% from the average session volume of 3,669,048 shares. The stock had previously closed at $29.61.
BBWI has been the topic of a number of analyst reports. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $56.00 to $51.00 and set an "overweight" rating on the stock in a research note on Thursday, September 5th. The Goldman Sachs Group decreased their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a "buy" rating for the company in a research report on Thursday, August 29th. Evercore ISI dropped their target price on Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating on the stock in a research report on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft reduced their price target on Bath & Body Works from $57.00 to $54.00 and set a "buy" rating for the company in a report on Monday, August 26th. Finally, Robert W. Baird dropped their price objective on Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating on the stock in a report on Thursday, August 29th. Eight research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $42.35.
View Our Latest Report on BBWI
The firm has a market capitalization of $6.84 billion, a P/E ratio of 7.96, a P/E/G ratio of 0.96 and a beta of 1.77. The stock's 50 day moving average is $31.00 and its two-hundred day moving average is $39.35.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 3.18 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were issued a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.61%. Bath & Body Works's dividend payout ratio is presently 20.62%.
Institutional investors and hedge funds have recently modified their holdings of the business. Anomaly Capital Management LP acquired a new position in shares of Bath & Body Works during the second quarter worth $113,995,000. Lone Pine Capital LLC lifted its holdings in Bath & Body Works by 20.0% during the fourth quarter. Lone Pine Capital LLC now owns 10,448,872 shares of the company's stock worth $450,973,000 after acquiring an additional 1,742,471 shares during the period. Vanguard Group Inc. increased its holdings in Bath & Body Works by 4.2% during the first quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company's stock worth $1,370,458,000 after buying an additional 1,102,124 shares during the last quarter. Interval Partners LP raised its holdings in shares of Bath & Body Works by 230.0% in the 2nd quarter. Interval Partners LP now owns 1,280,593 shares of the company's stock worth $50,007,000 after purchasing an additional 892,488 shares during the period. Finally, Ceredex Value Advisors LLC purchased a new position in shares of Bath & Body Works during the 2nd quarter valued at $25,867,000. 95.14% of the stock is currently owned by institutional investors.
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.